Pharmacology Bromocriptine
^ de leeuw van weenen, j. e.; parlevliet, e. t.; maechler, p.; havekes, l. m.; romijn, j. a.; ouwens, d. m.; pijl, h.; guigas, b. (2010). dopamine receptor d2 agonist bromocriptine inhibits glucose-stimulated insulin secretion direct activation of α2-adrenergic receptors in beta cells . biochemical pharmacology. 79 (12): 1827–36. doi:10.1016/j.bcp.2010.01.029. pmid 20138024.
^ shirasaki, y; sugimura, m; sato, t (september 2010). bromocriptine, ergot alkaloid, inhibits excitatory amino acid release mediated glutamate transporter reversal . european journal of pharmacology. 643 (1): 48–57. doi:10.1016/j.ejphar.2010.06.007. pmid 20599932.
^ national institute ofmental health. pdsd ki database (internet) [cited 2013 jul 24]. chapelhill (nc): university of north carolina. 1998-2013. available from: archived copy . archived original on 2013-11-08. retrieved 2013-11-26.
Comments
Post a Comment